U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 109

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr16:51173528
GRCh38:
Chr16:51139617
SALL1Q772E, Q869ETownes-Brocks syndrome 1Uncertain significance
(Mar 6, 2023)
criteria provided, single submitter
2.
GRCh37:
Chr16:51176029
GRCh38:
Chr16:51142118
SALL1R35LTownes-Brocks syndrome 1Uncertain significance
(Oct 18, 2022)
criteria provided, single submitter
3.
GRCh37:
Chr16:51173864
GRCh38:
Chr16:51139953
SALL1R660C, R757CTownes syndrome, Townes-Brocks syndrome 1Uncertain significance
(Mar 29, 2022)
criteria provided, multiple submitters, no conflicts
4.
GRCh37:
Chr16:51175300
GRCh38:
Chr16:51141389
SALL1S181F, S278FTownes-Brocks syndrome 1Uncertain significancecriteria provided, single submitter
5.
GRCh37:
Chr16:51174905
GRCh38:
Chr16:51140994
SALL1G313*, G410*Townes-Brocks syndrome 1Pathogenic
(Sep 1, 2022)
criteria provided, single submitter
6.
GRCh37:
Chr16:51174004
GRCh38:
Chr16:51140093
SALL1I613fs, I710fsTownes-Brocks syndrome 1Likely pathogenic
(Aug 2, 2022)
criteria provided, single submitter
7.
GRCh37:
Chr16:51172811
GRCh38:
Chr16:51138900
SALL1V1011F, V1108FTownes-Brocks syndrome 1Uncertain significance
(May 21, 2020)
criteria provided, single submitter
8.
GRCh37:
Chr16:51174355
GRCh38:
Chr16:51140444
SALL1S496N, S593NTownes-Brocks syndrome 1Uncertain significance
(Mar 25, 2022)
criteria provided, single submitter
9.
GRCh37:
Chr16:51175424
GRCh38:
Chr16:51141513
SALL1Q140*, Q237*Townes-Brocks syndrome 1Pathogenic
(Jun 3, 2022)
no assertion criteria provided
10.
GRCh37:
Chr16:51175412
GRCh38:
Chr16:51141501
SALL1I144V, I241VTownes-Brocks syndrome 1Uncertain significance
(Feb 1, 2022)
criteria provided, single submitter
11.
GRCh37:
Chr16:51175639
GRCh38:
Chr16:51141728
SALL1S165F, S68FTownes-Brocks syndrome 1Uncertain significance
(Jun 8, 2021)
criteria provided, single submitter
12.
GRCh37:
Chr16:51174764-51174770
GRCh38:
Chr16:51140853-51140859
SALL1Townes-Brocks syndrome 1Pathogenic
(Aug 1, 2021)
criteria provided, single submitter
13.
GRCh37:
Chr16:51175532
GRCh38:
Chr16:51141621
SALL1Q104*, Q201*Townes-Brocks syndrome 1Pathogenic/Likely pathogenic
(Aug 1, 2021)
criteria provided, multiple submitters, no conflicts
14.
GRCh37:
Chr16:51174358
GRCh38:
Chr16:51140447
SALL1K495R, K592RTownes-Brocks syndrome 1Uncertain significance
(Aug 1, 2021)
criteria provided, single submitter
15.
GRCh37:
Chr16:51174180
GRCh38:
Chr16:51140269
SALL1Townes syndrome, Townes-Brocks syndrome 1Likely benign
(Sep 8, 2022)
criteria provided, multiple submitters, no conflicts
16.
GRCh37:
Chr16:51175515
GRCh38:
Chr16:51141604
SALL1Townes syndrome, Townes-Brocks syndrome 1Likely benign
(May 6, 2022)
criteria provided, multiple submitters, no conflicts
17.
GRCh37:
Chr16:51173568
GRCh38:
Chr16:51139657
SALL1Townes syndrome, Townes-Brocks syndrome 1Likely benign
(Mar 29, 2022)
criteria provided, multiple submitters, no conflicts
18.
GRCh37:
Chr16:51172902
GRCh38:
Chr16:51138991
SALL1Townes syndrome, Townes-Brocks syndrome 1Likely benign
(Aug 16, 2022)
criteria provided, multiple submitters, no conflicts
19.
GRCh37:
Chr16:51173281
GRCh38:
Chr16:51139370
SALL1A951V, A854VTownes syndrome, Townes-Brocks syndrome 1Uncertain significance
(Apr 6, 2022)
criteria provided, multiple submitters, no conflicts
20.
GRCh37:
Chr16:51174906
GRCh38:
Chr16:51140995
SALL1Townes syndrome, Townes-Brocks syndrome 1Likely benign
(May 27, 2022)
criteria provided, multiple submitters, no conflicts
21.
GRCh37:
Chr16:51171270
GRCh38:
Chr16:51137359
SALL1N1146S, N1243STownes-Brocks syndrome 1, Townes syndromeUncertain significance
(May 6, 2022)
criteria provided, multiple submitters, no conflicts
22.
GRCh37:
Chr16:51173176
GRCh38:
Chr16:51139265
SALL1L889S, L986STownes-Brocks syndrome 1, Townes syndromeUncertain significance
(Oct 26, 2022)
criteria provided, multiple submitters, no conflicts
23.
GRCh37:
Chr16:51173186
GRCh38:
Chr16:51139275
SALL1E886Q, E983QTownes syndrome, Townes-Brocks syndrome 1Uncertain significance
(Feb 8, 2022)
criteria provided, multiple submitters, no conflicts
24.
GRCh37:
Chr16:51172752
GRCh38:
Chr16:51138841
SALL1R1031fs, R1128fsTownes-Brocks syndrome 1Likely pathogenic
(Jan 3, 2022)
criteria provided, single submitter
25.
GRCh37:
Chr16:51173195
GRCh38:
Chr16:51139284
SALL1I883F, I980FTownes-Brocks syndrome 1, not providedUncertain significance
(May 7, 2022)
criteria provided, multiple submitters, no conflicts
26.
GRCh37:
Chr16:51171367
GRCh38:
Chr16:51137456
SALL1V1114F, V1211FTownes-Brocks syndrome 1, not providedUncertain significance
(Nov 17, 2021)
criteria provided, multiple submitters, no conflicts
27.
GRCh37:
Chr16:51175117
GRCh38:
Chr16:51141206
SALL1P242L, P339LTownes-Brocks syndrome 1, not providedUncertain significance
(Mar 23, 2022)
criteria provided, multiple submitters, no conflicts
28.
GRCh37:
Chr16:51171216
GRCh38:
Chr16:51137305
SALL1P1164R, P1261RTownes-Brocks syndrome 1, not providedUncertain significance
(Dec 6, 2021)
criteria provided, multiple submitters, no conflicts
29.
GRCh37:
Chr16:51175914
GRCh38:
Chr16:51142003
SALL1not provided, Townes syndrome, Townes-Brocks syndrome 1
Benign/Likely benign
(Sep 10, 2022)
criteria provided, multiple submitters, no conflicts
30.
GRCh37:
Chr16:51172823
GRCh38:
Chr16:51138912
SALL1P1007A, P1104ATownes syndrome, not provided, Townes-Brocks syndrome 1
Benign/Likely benign
(Oct 3, 2022)
criteria provided, multiple submitters, no conflicts
31.
GRCh37:
Chr16:51174568
GRCh38:
Chr16:51140657
SALL1T425M, T522Mnot provided, Townes-Brocks syndrome 1Benign/Likely benign
(Jan 28, 2022)
criteria provided, multiple submitters, no conflicts
32.
GRCh37:
Chr16:51173802
GRCh38:
Chr16:51139891
SALL1Townes syndrome, not provided, Townes-Brocks syndrome 1
Benign/Likely benign
(May 25, 2022)
criteria provided, multiple submitters, no conflicts
33.
GRCh37:
Chr16:51171269
GRCh38:
Chr16:51137358
SALL1Townes syndrome, not provided, Townes-Brocks syndrome 1
Benign/Likely benign
(Sep 1, 2022)
criteria provided, multiple submitters, no conflicts
34.
GRCh37:
Chr16:51174926
GRCh38:
Chr16:51141015
SALL1P306S, P403Snot provided, Townes-Brocks syndrome 1Uncertain significance
(Aug 23, 2021)
criteria provided, multiple submitters, no conflicts
35.
GRCh37:
Chr16:51173874
GRCh38:
Chr16:51139963
SALL1Townes-Brocks syndrome 1, not providedLikely benign
(Dec 20, 2021)
criteria provided, multiple submitters, no conflicts
36.
GRCh37:
Chr16:51172803
GRCh38:
Chr16:51138892
SALL1not provided, Townes-Brocks syndrome 1Likely benign
(Dec 23, 2021)
criteria provided, multiple submitters, no conflicts
37.
GRCh37:
Chr16:51175709
GRCh38:
Chr16:51141798
SALL1G142R, G45RTownes-Brocks syndrome 1Uncertain significance
(Jul 10, 2020)
criteria provided, single submitter
38.
GRCh37:
Chr16:51174374
GRCh38:
Chr16:51140463
SALL1P490T, P587TTownes-Brocks syndrome 1Uncertain significance
(Jan 4, 2021)
criteria provided, single submitter
39.
GRCh37:
Chr16:51175863-51175864
GRCh38:
Chr16:51141952-51141953
SALL1P91fsTownes-Brocks syndrome 1Likely pathogenic
(Mar 25, 2021)
criteria provided, single submitter
40.
GRCh37:
Chr16:51173045
GRCh38:
Chr16:51139134
SALL1I1030V, I933VTownes syndrome, Townes-Brocks syndrome 1Uncertain significance
(Jan 3, 2022)
criteria provided, multiple submitters, no conflicts
41.
GRCh37:
Chr16:51173287
GRCh38:
Chr16:51139376
SALL1Q852R, Q949RTownes-Brocks syndrome 1Uncertain significance
(Jun 11, 2020)
criteria provided, single submitter
42.
GRCh37:
Chr16:51174767-51174768
GRCh38:
Chr16:51140856-51140857
SALL1K359fs, K456fsTownes-Brocks syndrome 1Pathogenic
(Jul 23, 2020)
criteria provided, single submitter
43.
GRCh37:
Chr16:51171216
GRCh38:
Chr16:51137305
SALL1P1164L, P1261LTownes-Brocks syndrome 1Uncertain significance
(Aug 26, 2020)
criteria provided, single submitter
44.
GRCh37:
Chr16:51171151
GRCh38:
Chr16:51137240
SALL1E1186K, E1283KTownes-Brocks syndrome 1Uncertain significance
(Mar 31, 2020)
criteria provided, single submitter
45.
GRCh37:
Chr16:51174260
GRCh38:
Chr16:51140349
SALL1E528*, E625*Townes-Brocks syndrome 1Pathogenic
(Jul 23, 2017)
criteria provided, single submitter
46.
GRCh37:
Chr16:51171211
GRCh38:
Chr16:51137300
SALL1I1166V, I1263VTownes-Brocks syndrome 1Uncertain significance
(Aug 27, 2021)
criteria provided, multiple submitters, no conflicts
47.
GRCh37:
Chr16:51175721
GRCh38:
Chr16:51141810
SALL1G41S, G138STownes syndrome, not provided, Townes-Brocks syndrome 1
Conflicting interpretations of pathogenicity
(Dec 7, 2022)
criteria provided, conflicting interpretations
48.
GRCh37:
Chr16:51173845-51173846
GRCh38:
Chr16:51139934-51139935
SALL1R666fs, R763fsTownes-Brocks syndrome 1Likely pathogenic
(Oct 4, 2019)
no assertion criteria provided
49.
GRCh37:
Chr16:51174083
GRCh38:
Chr16:51140172
SALL1Q587*, Q684*Townes-Brocks syndrome 1Uncertain significance
(Feb 7, 2018)
criteria provided, single submitter
50.
GRCh37:
Chr16:51171162
GRCh38:
Chr16:51137251
SALL1T1182M, T1279MInborn genetic diseases, Townes syndrome, not provided
Uncertain significance
(Mar 4, 2022)
criteria provided, multiple submitters, no conflicts
51.
GRCh37:
Chr16:51173332
GRCh38:
Chr16:51139421
SALL1S837fs, S934fsTownes-Brocks syndrome 1Likely pathogenic
(Aug 13, 2019)
no assertion criteria provided
52.
GRCh37:
Chr16:51173443-51173444
GRCh38:
Chr16:51139532-51139533
SALL1V897fs, V800fsTownes-Brocks syndrome 1Pathogenic
(Aug 10, 2018)
criteria provided, single submitter
53.
GRCh37:
Chr16:51175430
GRCh38:
Chr16:51141519
SALL1A235T, A138Tnot provided, Townes-Brocks syndrome 1Conflicting interpretations of pathogenicity
(May 28, 2020)
criteria provided, conflicting interpretations
54.
GRCh37:
Chr16:51173049
GRCh38:
Chr16:51139138
SALL1not provided, Townes-Brocks syndrome 1Likely benign
(Aug 16, 2021)
criteria provided, multiple submitters, no conflicts
55.
GRCh37:
Chr16:51175655-51175656
GRCh38:
Chr16:51141744-51141745
SALL1Townes-Brocks syndrome 1, Townes syndrome, not provided
Benign/Likely benign
(Oct 5, 2022)
criteria provided, multiple submitters, no conflicts
56.
GRCh37:
Chr16:51174619
GRCh38:
Chr16:51140708
SALL1H408R, H505RTownes-Brocks syndrome 1Uncertain significance
(Aug 4, 2019)
criteria provided, single submitter
57.
GRCh37:
Chr16:51172811
GRCh38:
Chr16:51138900
SALL1V1011I, V1108Inot specified, Townes-Brocks syndrome 1Likely benign
(Dec 29, 2021)
criteria provided, multiple submitters, no conflicts
58.
GRCh37:
Chr16:51175585
GRCh38:
Chr16:51141674
SALL1T183K, T86KTownes-Brocks syndrome 1, Townes syndromeConflicting interpretations of pathogenicity
(Jul 19, 2022)
criteria provided, conflicting interpretations
59.
GRCh37:
Chr16:51175531
GRCh38:
Chr16:51141620
SALL1Q201R, Q104Rnot provided, VACTERL with hydrocephalus, Townes-Brocks syndrome 1
Uncertain significance
(Mar 1, 2022)
criteria provided, multiple submitters, no conflicts
60.
GRCh37:
Chr16:51175869
GRCh38:
Chr16:51141958
SALL1not provided, Townes syndrome, Townes-Brocks syndrome 1
Benign/Likely benign
(Aug 26, 2022)
criteria provided, multiple submitters, no conflicts
61.
GRCh37:
Chr16:51175655-51175656
GRCh38:
Chr16:51141744-51141745
SALL1not provided, Townes-Brocks syndrome 1Uncertain significance
(Mar 25, 2022)
criteria provided, multiple submitters, no conflicts
62.
GRCh37:
Chr16:51175746
GRCh38:
Chr16:51141835
SALL1Townes syndrome, Townes-Brocks syndrome 1, not specified
Likely benign
(Oct 16, 2022)
criteria provided, multiple submitters, no conflicts
63.
GRCh37:
Chr16:51175772
GRCh38:
Chr16:51141861
SALL1R121G, R24Gnot provided, Townes-Brocks syndrome 1Uncertain significance
(Jul 23, 2021)
criteria provided, multiple submitters, no conflicts
64.
GRCh37:
Chr16:51173855
GRCh38:
Chr16:51139944
SALL1P760S, P663Snot provided, Townes-Brocks syndrome 1Uncertain significance
(Apr 29, 2022)
criteria provided, multiple submitters, no conflicts
65.
GRCh37:
Chr16:51172953
GRCh38:
Chr16:51139042
SALL1Townes syndrome, not specified, not provided,
Townes-Brocks syndrome 1
Benign/Likely benign
(Sep 2, 2021)
criteria provided, multiple submitters, no conflicts
66.
GRCh37:
Chr16:51172934
GRCh38:
Chr16:51139023
SALL1L1067F, L970FTownes-Brocks syndrome 1, Townes syndromeConflicting interpretations of pathogenicity
(Jul 6, 2022)
criteria provided, conflicting interpretations
67.
GRCh37:
Chr16:51175024-51175025
GRCh38:
Chr16:51141113-51141114
SALL1V273fs, V370fsTownes-Brocks syndrome 1Pathogenic
(Apr 26, 2017)
criteria provided, single submitter
68.
GRCh37:
Chr16:51172718-51172719
GRCh38:
Chr16:51138807-51138808
SALL1C1042fs, C1139fsnot provided, Townes-Brocks syndrome 1, Townes syndrome
Pathogenic
(Jul 17, 2022)
criteria provided, multiple submitters, no conflicts
69.
GRCh37:
Chr16:51171227
GRCh38:
Chr16:51137316
SALL1not specified, Townes syndrome, Townes-Brocks syndrome 1
Likely benign
(Feb 7, 2022)
criteria provided, multiple submitters, no conflicts
70.
GRCh37:
Chr16:51185110
GRCh38:
Chr16:51151199
SALL1D15NTownes-Brocks syndrome 1Uncertain significance
(Jun 14, 2016)
criteria provided, single submitter
71.
GRCh37:
Chr16:51175782
GRCh38:
Chr16:51141871
SALL1Townes syndrome, Townes-Brocks syndrome 1, not provided
Likely benign
(Sep 2, 2022)
criteria provided, multiple submitters, no conflicts
72.
GRCh37:
Chr16:51175655-51175656
GRCh38:
Chr16:51141744-51141745
SALL1not provided, Townes syndrome, not specified,
Townes-Brocks syndrome 1
Conflicting interpretations of pathogenicity
(Oct 24, 2022)
criteria provided, conflicting interpretations
73.
GRCh37:
Chr16:51175596
GRCh38:
Chr16:51141685
SALL1Townes syndrome, not provided, Townes-Brocks syndrome 1
Benign/Likely benign
(Oct 29, 2021)
criteria provided, multiple submitters, no conflicts
74.
GRCh37:
Chr16:51172911
GRCh38:
Chr16:51139000
SALL1Townes syndrome, not provided, Townes-Brocks syndrome 1
Benign/Likely benign
(Oct 27, 2022)
criteria provided, multiple submitters, no conflicts
75.
GRCh37:
Chr16:51171056
GRCh38:
Chr16:51137145
SALL1not provided, not specified, Townes-Brocks syndrome 1,
Townes syndrome
Benign/Likely benign
(Oct 20, 2022)
criteria provided, multiple submitters, no conflicts
76.
GRCh37:
Chr16:51170931-51170935
GRCh38:
Chr16:51137020-51137024
SALL1Townes-Brocks syndrome 1, not providedLikely benign
(Mar 31, 2019)
criteria provided, multiple submitters, no conflicts
77.
GRCh37:
Chr16:51170460
GRCh38:
Chr16:51136549
SALL1Townes-Brocks syndrome 1Uncertain significance
(Jun 14, 2016)
criteria provided, single submitter
78.
GRCh37:
Chr16:51170435
GRCh38:
Chr16:51136524
SALL1Townes-Brocks syndrome 1Benign
(Jun 14, 2016)
criteria provided, single submitter
79.
GRCh37:
Chr16:51170317-51170318
GRCh38:
Chr16:51136406-51136407
SALL1Townes-Brocks syndrome 1Uncertain significance
(Jun 14, 2016)
criteria provided, single submitter
80.
GRCh37:
Chr16:51170095-51170097
GRCh38:
Chr16:51136184-51136186
SALL1not provided, Townes-Brocks syndrome 1Conflicting interpretations of pathogenicity
(Nov 1, 2022)
criteria provided, conflicting interpretations
81.
GRCh37:
Chr16:51169989-51169990
GRCh38:
Chr16:51136078-51136079
SALL1Townes-Brocks syndrome 1Uncertain significance
(Jun 14, 2016)
criteria provided, single submitter
82.
GRCh37:
Chr16:51169910-51169911
GRCh38:
Chr16:51135999-51136000
SALL1Townes-Brocks syndrome 1Likely benign
(Jun 14, 2016)
criteria provided, single submitter
83.
GRCh37:
Chr16:51175649
GRCh38:
Chr16:51141738
SALL1G162S, G65Snot provided, Townes-Brocks syndrome 1, Townes syndrome
Uncertain significance
(Sep 27, 2022)
criteria provided, multiple submitters, no conflicts
84.
GRCh37:
Chr16:51174804
GRCh38:
Chr16:51140893
SALL1D443E, D346Enot provided, Townes-Brocks syndrome 1Uncertain significance
(Feb 4, 2022)
criteria provided, multiple submitters, no conflicts
85.
GRCh37:
Chr16:51171204
GRCh38:
Chr16:51137293
SALL1G1265E, G1168ETownes syndrome, not specified, not provided,
Townes-Brocks syndrome 1
Benign/Likely benign
(Sep 17, 2022)
criteria provided, multiple submitters, no conflicts
86.
GRCh37:
Chr16:51175643-51175644
GRCh38:
Chr16:51141732-51141733
SALL1not specified, Townes syndrome, not provided,
Townes-Brocks syndrome 1
Conflicting interpretations of pathogenicity
(Jul 17, 2022)
criteria provided, conflicting interpretations
87.
GRCh37:
Chr16:51175658
GRCh38:
Chr16:51141747
SALL1S159G, S62Gnot provided, not specified, Townes syndrome,
Townes-Brocks syndrome 1
Benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
88.
GRCh37:
Chr16:51175655-51175656
GRCh38:
Chr16:51141744-51141745
SALL1not specified, not provided, Townes syndrome,
Townes-Brocks syndrome 1
Benign/Likely benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
89.
GRCh37:
Chr16:51171175
GRCh38:
Chr16:51137264
SALL1V1275I, V1178Inot provided, not specified, Townes syndrome,
Townes-Brocks syndrome 1
Benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
90.
GRCh37:
Chr16:51172677
GRCh38:
Chr16:51138766
SALL1Townes syndrome, not provided, Townes-Brocks syndrome 1,
not specified
Benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
91.
GRCh37:
Chr16:51173559
GRCh38:
Chr16:51139648
SALL1not provided, not specified, Townes syndrome,
Townes-Brocks syndrome 1
Benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
92.
GRCh37:
Chr16:51175656-51175664
GRCh38:
Chr16:51141745-51141753
SALL1not specified, Townes-Brocks syndrome 1, not provided,
Townes syndrome
Conflicting interpretations of pathogenicity
(Nov 1, 2022)
criteria provided, conflicting interpretations
93.
GRCh37:
Chr16:51176003
GRCh38:
Chr16:51142092
SALL1V44Inot provided, Townes-Brocks syndrome 1Conflicting interpretations of pathogenicity
(Dec 19, 2019)
criteria provided, conflicting interpretations
94.
GRCh37:
Chr16:51172973
GRCh38:
Chr16:51139062
SALL1R1054*, R957*Townes syndrome, not providedPathogenic/Likely pathogenic
(Nov 7, 2022)
criteria provided, multiple submitters, no conflicts
95.
GRCh37:
Chr16:51171126
GRCh38:
Chr16:51137215
SALL1N1291S, N1194STownes syndrome, not specified, not provided,
Townes-Brocks syndrome 1
Benign/Likely benign
(Oct 21, 2022)
criteria provided, multiple submitters, no conflicts
96.
GRCh37:
Chr16:51175184
GRCh38:
Chr16:51141273
SALL1P317S, P220Snot provided, Townes-Brocks syndrome 1Conflicting interpretations of pathogenicity
(Apr 14, 2022)
criteria provided, conflicting interpretations
97.
GRCh37:
Chr16:51173013
GRCh38:
Chr16:51139102
SALL1not specified, not provided, Townes syndrome,
Townes-Brocks syndrome 1
Benign/Likely benign
(Jul 25, 2022)
criteria provided, multiple submitters, no conflicts
98.
GRCh37:
Chr16:51173850
GRCh38:
Chr16:51139939
SALL1not provided, Townes-Brocks syndrome 1Uncertain significance
(Jan 12, 2022)
criteria provided, multiple submitters, no conflicts
99.
GRCh37:
Chr16:51175656-51175658
GRCh38:
Chr16:51141745-51141747
SALL1S159del, S62delTownes syndrome, not specified, not provided,
Townes-Brocks syndrome 1
Conflicting interpretations of pathogenicity
(Oct 18, 2022)
criteria provided, conflicting interpretations
100.
GRCh37:
Chr16:51175138
GRCh38:
Chr16:51141227
SALL1P235fs, P332fsTownes-Brocks syndrome 1Pathogenic
(Dec 15, 2007)
no assertion criteria provided
Format
Items per page
Sort by
Choose Destination